ClassID:

21647

A61K2300/00 - page 41 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#12001
20100137251
2010-06-03

Functional role for cannabinoids in autonomic stability during sleep

#12002
20100137247
2010-06-03

Anti-inflammatory compositions and methods

#12003
20100137239
2010-06-03

GEMCITABINE COMBINATION THERAPY

#12004
20100137235
2010-06-03

Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics

#12005
20100137232
2010-06-03

COMPOSITION COMPRISING A DIURETIC AND A CARDIAC GLYCOSIDE FOR THE TREATMENT OF DNA VIRAL INFECTIONS OF THE EYE

#12006
20100137211
2010-06-03

METHODS AND COMPOSITIONS FOR INTRA-ARTICULAR COAGULATION PROTEINS

#12007
20100137205
2010-06-03

Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation

#12008
20100137200
2010-06-03

Methods for treatment of insulin-like growth factor-1 deficiency

#12009
20100137198
2010-06-03

Pharmaceutical composition for topical application

#12010
20100137192
2010-06-03

COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING MYCOBACTERIAL INFECTIONS

#12011
20100137186
2010-06-03

USE OF AN ACTIVE PRINCIPLE ORIGINATING FROM AMARANTH (AMARANTHUS) FOR PREPARING A COMPOSITION INTENDED TO ACTIVATE CELLULAR ENERGY AND TO PROTECT THE SKIN FROM OXIDATIVE DAMAGE

#12012
20100136597
2010-06-03

METHOD FOR MODULARTING ACTIVITY OF T LYMPHOCYTES

#12013
20100136146
2010-06-03

Composition for heart disease, its active ingredients, method to prepare same and uses thereof

#12014
20100136145
2010-06-03

Formulations containing and extracts which are useful in the treatment of obesity

#12015
20100136141
2010-06-03

Hemostatic agent

#12016
20100136140
2010-06-03

A USE OF HYPERTONIC SOLUTION COMPOSITION IN MANUFACTURING MEDICAMENTS FOR PROMOTING WOUND HEALING

#12017
20100136138
2010-06-03

Treatment of lung cancer

#12018
20100136137
2010-06-03

THERAPEUTIC COMBINATION OF A PANHER/VEGFR2 KINASE INHIBITOR AND A PLATINUM COMPOUND

#12019
20100136133
2010-06-03

Nutritive compositions and methods of using same

#12020
20100136127
2010-06-03

Solid preparation comprising alogliptin and metformin hydrochloride

#12021
20100136121
2010-06-03

MEDICAMENTS

#12022
20100136120
2010-06-03

Compositions and methods for forming and strengthening bone

#12023
20100136114
2010-06-03

DE NOVO FORMATION AND REGENERATION OF VASCULARIZED TISSUE FROM TISSUE PROGENITOR CELLS AND VASCULAR PROGENTITOR CELLS

#12024
20100136111
2010-06-03

PHARMACEUTICAL COMPOSITIONS OF DICLOFENAC AND MISOPROSTOL

#12025
20100136107
2010-06-03

Liquid therapeutic composition

#12026
20100136105
2010-06-03

PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS

#12027
20100136104
2010-06-03

Nutritional supplement for use under physiologically stressful conditions

#12028
20100136096
2010-06-03

Systems for modulating inflammation

#12029
20100136095
2010-06-03

Systems for modulating inflammation

#12030
20100136094
2010-06-03

Systems for modulating inflammation

#12031
20100136068
2010-06-03

DERMATOLOGICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF ROSACEA, OF COUPEROSE OR OF SKIN WHICH EXHIBITS DIFFUSE REDNESS OR SMALL DILATED VESSELS

#12032
20100136067
2010-06-03

Oral care product

#12033
20100136064
2010-06-03

Nutraceutical composition

#12034
20100136044
2010-06-03

Dietary supplement and method

#12035
20100136041
2010-06-03

COMBINATION GAS VACCINES AND THERAPEUTICS

#12036
20100136029
2010-06-03

Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological Malignancies

#12037
20100136026
2010-06-03

Ship Inhibition to Direct Hematopoietic Stem Cells and Induce Extramedullary Hematopoiesis

#12038
20100136020
2010-06-03

USES OF IL-174 ANTAGONISTS FOR INHIBITING A TH2 IMMUNE RESPONSE

#12039
20100136009
2010-06-03

OVR110 antibody compositions and methods of use

#12040
20100135998
2010-06-03

COMBINATION THERAPY FOR TREATMENT OF IMMUNE DISORDERS

#12041
20100135983
2010-06-03

Anti-inflammatory compositions and methods

#12042
20100135971
2010-06-03

Probiotics in a pre- and/or post surgical environment

#12043
20100135968
2010-06-03

Oligodendrocyte Production From Multipotent Neural Stem Cells

#12044
20100135960
2010-06-03

ANTIVIRAL ACYLSULFONAMIDE DERIVATIVES

#12045
20100135958
2010-06-03

METHOD FOR TREATING CANCER IN HUMANS

#12046
20100135956
2010-06-03

STEROID MODULATORS OF PROGESTERONE RECEPTOR AND/OR GLUCOCORTICOID RECEPTOR

#12047
20100135951
2010-06-03

Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists

#12048
20100135950
2010-06-03

Iron(II)-Containing Treatments for Hyperphosphatemia

#12049
20100135935
2010-06-03

Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications

#12050
20100135919
2010-06-03

Proteolytic enzyme formulations

#12051
20100135908
2010-06-03

Delivery devices for modulating inflammation

#12052
20100135902
2010-06-03

Papillomavirus pseudoviruses for detection and therapy of tumors

#12053
20100135901
2010-06-03

COMBINATION THERAPY

#12054
20100135900
2010-06-03

CD37 IMMUNOTHERAPEUTIC COMBINATION THERAPIES AND USES THEREOF

#12055
20100130912
2010-05-27

Patches and methods for the transdermal delivery of a therapeutically effective amount of iron

#12056
20100130910
2010-05-27

Patches and method for the transdermal delivery of a therapeutically effective amount of iron

#12057
20100130735
2010-05-27

Antiviral nucleosides

#12058
20100130617
2010-05-27

ETHANOLAMINE MODULATORS OF NMDA RECEPTOR AND MUSCARINIC ACETYLCHOLINE RECEPTOR

#12059
20100130615
2010-05-27

SULFONYLUREA INHIBITORS OF ATP-SENSITIVE POTASSIUM CHANNELS

#12060
20100130608
2010-05-27

COMPOSITIONS AND METHODS FOR REDUCING TRIGLYCERIDE LEVELS

#12061
20100130603
2010-05-27

MEDICAMENT FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF DERMATOSIS RESULTING FROM EXCESSIVELY ADVANCED KERATINIZATION

#12062
20100130597
2010-05-27

DNA-PKCS MODULATES ENERGY REGULATION AND BRAIN FUNCTION

#12063
20100130593
2010-05-27

METHODS AND IMMUNE MODULATOR NUCLEIC ACID COMPOSITIONS FOR PREVENTING AND TREATING DISEASE

#12064
20100130573
2010-05-27

Treatment and prevention of deleterious effects associated with alcohol consumption

#12065
20100130542
2010-05-27

Composition comprising omeprazole, lansoprazole and at least one buffering agent

#12066
20100130537
2010-05-27

CINNAMIDE COMPOUNDS FOR DEMENTIA

#12067
20100130520
2010-05-27

COMBINATION THERAPY

#12068
20100130519
2010-05-27

COMBINATION THERAPY COMPRISING AZD2171 AND AZD6244 OR MEK-INHIBITOR II

#12069
20100130514
2010-05-27

FUSED HETEROCYCLIC DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING THE DERIVATIVE, AND USE OF THE COMPOSITION FOR MEDICAL PURPOSES

#12070
20100130504
2010-05-27

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes

#12071
20100130502
2010-05-27

Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders

#12072
20100130493
2010-05-27

COMBINATION OF VEGF RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF CANCER

#12073
20100130465
2010-05-27

2-aminothiazole-4-carboxylic amides as protein kinase inhibitors

#12074
20100130457
2010-05-27

Phenothiazine Derivatives for Treatment of Asthma

#12075
20100130456
2010-05-27

Drug combination and its use in the treatment of muscle loss

#12076
20100130452
2010-05-27

Use of Doxycycline in the Treatment of Idiopathic Pulmonary Fibrosis

#12077
20100130450
2010-05-27

Methods of Treating Fungal Infections

#12078
20100130436
2010-05-27

CO-ADMINISTRATION OF RANOLAZINE AND CARDIAC GLYCOSIDES

#12079
20100130426
2010-05-27

Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent

#12080
20100130418
2010-05-27

P2Xinhibition of epithelial cancers and papillomas

#12081
20100130415
2010-05-27

Stem cell secreted product derived compositions for wound treatment

#12082
20100130411
2010-05-27

Method for treating cartilage disorders

#12083
20100130408
2010-05-27

USE OF MODIFIED CYCLOSPORINS

#12084
20100130401
2010-05-27

PROTEIN HYDROLYSATE AND PLANT STEROL CONTAINING COMPOSITION FOR IMPROVING SERUM LIPID PROFILE AND PREVENTING ATHEROSCLERORIS

#12085
20100129890
2010-05-27

Cytochrome P450 enzyme complexes and methods of treatment using the same

#12086
20100129496
2010-05-27

NUTRITIONAL FORMULATIONS

#12087
20100129477
2010-05-27

COMPOSITION FOR TREATMENT OF SKIN DISORDERS

#12088
20100129476
2010-05-27

COMPOSITION COMPRISING REHMANNIAE RADIX PREPARATA, NOTOGINSENG RADIX OR MIXTURE EXTRACT THEREOF FOR PREVENTING AND TREATING OF PERIODONTITIS AS AN EFFECTIVE COMPONENT

#12089
20100129472
2010-05-27

Compositions And Method For The Treatment Of Acne

#12090
20100129469
2010-05-27

Use of dimiracetam in the treatment of chronic pain

#12091
20100129458
2010-05-27

Compositions and methods for inhibiting reproduction in tadpole shrimp

#12092
20100129442
2010-05-27

Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors

#12093
20100129441
2010-05-27

Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa

#12094
20100129434
2010-05-27

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUCORMYCOSIS AND OTHER FUNGAL DISEASES

#12095
20100129432
2010-05-27

MICROORGANISM-KILLING COMBINATION

#12096
20100129429
2010-05-27

Inhibition of autophagy genes in cancer chemotherapy

#12097
20100129426
2010-05-27

PROTECTIVE AGENT AGAINST DAMAGE OF BIOLOGICAL TISSUE CAUSED BY NEAR-INFRARED RAY AND PRODUCT COMPRISING THE SAME

#12098
20100129417
2010-05-27

Dihydroxybenzoate polymers and uses thereof

#12099
20100129382
2010-05-27

Combination therapy for the treatment of tumors

#12100
20100129372
2010-05-27

INHIBITION OF PACAP SIGNALLING FOR THE PREVENTION AND TREATMENT OF THROMBOCYTOPENIA

#12101
20100129366
2010-05-27

THIAZOLE INHIBITORS OF CYCLOOXYGENASE

#12102
20100129364
2010-05-27

Combination therapy for the treatment of ocular neovascular disorders

#12103
20100129356
2010-05-27

COMPOSITIONS AND METHODS FOR MODULATING VASCULAR DEVELOPMENT

#12104
20100129353
2010-05-27

COMBINATION AND TREATMENT FOR MULTIPLE SCLEROSIS

#12105
20100129335
2010-05-27

Reduction of risk diarrhoea

#12106
20100129332
2010-05-27

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS

#12107
20100129331
2010-05-27

Disaccharides for the treatment of tendons, ligaments, and bones

#12108
20100129324
2010-05-27

Biological effects of compositions comprising rosmarinic acid

#12109
20100129321
2010-05-27

DIARYL UREA FOR TREATING VIRUS INFECTIONS

#12110
20100129319
2010-05-27

TREATMENT OF DISEASE OR INJURY OF THE NERVOUS SYSTEM USING AGENTS THAT DECREASE THE ACTIVITY OF THE MELANOCORTIN 4 RECEPTOR

#12111
20100129315
2010-05-27

Anti-MN antibodies and methods of using same

#12112
20100126256
2010-05-27

Menstrual fluid simulant

#12113
20100125098
2010-05-20

Treatment of cancer with complex organic-inorganic pigment compositions

#12114
20100125097
2010-05-20

Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof

#12115
20100125070
2010-05-20

Bupropion Metabolites and Methods of Their Synthesis and Use

#12116
20100125068
2010-05-20

Methods for inhibiting protein kinases

#12117
20100125063
2010-05-20

COMBINATIONS OF NICOTINIC ACETYLCHOLINE ALPHA 7 RECEPTOR AGONISTS

#12118
20100125057
2010-05-20

TOPICAL SKIN CARE COMPOSITION

#12119
20100125052
2010-05-20

Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents

#12120
20100124578
2010-05-20

Appetite-suppressing weight management composition

#12121
20100124576
2010-05-20

Topical Treatment Formulation of Natural Ingredients for Enhancing Sexual Response

#12122
20100124575
2010-05-20

Method for pain control

#12123
20100124571
2010-05-20

Use of pH-sensitive, Acid-Stable Metal-Binding Nanoparticles

#12124
20100124553
2010-05-20

Methods for Treatment of HIV and Other Infections Using A T Cell or Viral Activator and Anti-Retroviral Combination Therapy

#12125
20100124549
2010-05-20

Composition and method for treatment of bruising

#12126
20100124541
2010-05-20

HYDROXYADAMANTYL INHIBITORS OF DIPEPTIDYLPEPTIDASE IV

#12127
20100124537
2010-05-20

MEDICAL APPLICATIONS OF ALPHA-KETOGLUTARATE

#12128
20100122918
2010-05-20

Ophthalmic and contact lens solution

#12129
20100121466
2010-05-13

Frozen compositions and methods for piercing a substrate

#12130
20100121459
2010-05-13

Tetra calcium phosphate based organophosphorus compositions and methods

#12131
20100121027
2010-05-13

Cyclic peptide compositions for treatment of sexual dysfunction

#12132
20100120916
2010-05-13

THERAPEUTIC AGENT AND DIAGNOSTIC AGENT FOR MITOCHONDRIAL DYSFUNCTION BRAIN DISEASES

#12133
20100120912
2010-05-13

Esters of capsaicinoids as dietary supplements

#12134
20100120889
2010-05-13

Skin care composition for accelerated production of collagen proteins and method of fabricating the same

#12135
20100120868
2010-05-13

Process For Preparing Solid Dosage Forms of Rosiglitazone Maleate

#12136
20100120853
2010-05-13

Derivatives of hypoestoxide and related compounds

#12137
20100120842
2010-05-13

NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION

#12138
20100120812
2010-05-13

Medicinal compositions comprising buprenorphine and naltrexone

#12139
20100120782
2010-05-13

Endoparasiticidal gel composition

#12140
20100120780
2010-05-13

TREATMENTS FOR PREMATURE EJACULATION IN HUMANS

#12141
20100120777
2010-05-13

Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin

#12142
20100120776
2010-05-13

Carbocysteine medical foods

#12143
20100120747
2010-05-13

COMBINATION OF A CHOLINESTERASE INHIBITOR AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY

#12144
20100120746
2010-05-13

USE OF R-10-HYDROXY-10,11-DIHYDRO-CARBAMAZEPINE IN NEUROPATHIC PAIN

#12145
20100120742
2010-05-13

Rexinoid compound having alkoxy group

#12146
20100120734
2010-05-13

FORMOTEROL/STEROID BRONCHODILATING COMPOSITIONS AND METHODS OF USE THEREOF

#12147
20100120733
2010-05-13

STEROID MODULATORS OF GLUCOCORTICOID RECEPTOR

#12148
20100120727
2010-05-13

Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof

#12149
20100120726
2010-05-13

1-methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities

#12150
20100120720
2010-05-13

HMG-CoA reductase and farnesyl-pyrophosphate synthase inhibitors for the treatment of conditions related to prenylated proteins in cells

#12151
20100120718
2010-05-13

COMBINATION THERAPY OF SUBSTITUTED OXAZOLIDINONES

#12152
20100120708
2010-05-13

Combination therapy comprising ZD6474 and gemcitabine for anti-cancer therapy

#12153
20100120702
2010-05-13

Solid preparation for dialysis

#12154
20100120687
2010-05-13

Modulating apoptosis

#12155
20100120682
2010-05-13

COMPOSITIONS FOR INCREASING BODY WEIGHT, USE AND METHODS

#12156
20100120676
2010-05-13

Composition to treat and/or prevent gastrointestinal infection

#12157
20100120662
2010-05-13

Glucose uptake modulator and method for treating diabetes or diabetic complications

#12158
20100120140
2010-05-13

Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN

#12159
20100120122
2010-05-13

Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein

#12160
20100119633
2010-05-13

Analgesic oil containing plant based extracts from solar infusions

#12161
20100119629
2010-05-13

Angina pectoris and ischemic heart disease and synergistic phytoceutical composition for same

#12162
20100119624
2010-05-13

BENZISOXAZOLE MODULATORS OF D2 RECEPTOR AND/OR 5-HT2A RECEPTOR

#12163
20100119623
2010-05-13

IMIDAZOLYL MODULATORS OF 5-HT3 RECEPTORS

#12164
20100119622
2010-05-13

3H-BENZOOXAZOL-2-ONE MODULATORS OF D2 RECEPTOR AND/OR 5-HT1A RECEPTOR

#12165
20100119614
2010-05-13

PROCESS FOR THE MANUFACTURE OF A DAIRY-BASED ANTI-INFLAMMATORY COMPOSITION

#12166
20100119609
2010-05-13

METHODS, COMPOSITIONS, AND FORMULATIONS FOR THE TREATMENT OF THYROID EYE DISEASE

#12167
20100119608
2010-05-13

Synthesis of pH-sensitive, Acid-Stable Metal-Binding Nanoparticles

#12168
20100119605
2010-05-13

COMPOSITIONS FOR TISSUE STABILIZATION

#12169
20100119602
2010-05-13

PHOSPHATE BINDER WITH REDUCED PILL BURDEN

#12170
20100119600
2010-05-13

SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING RED YEAST RICE EXTRACT AND OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVE THEREOF

#12171
20100119592
2010-05-13

CYTARABINE FOR TREATMENT OF GLIOMA

#12172
20100119589
2010-05-13

LIPOSOMAL COMPOSITION OF ANTIOXIDANTS FOR INHALATIONS CARRIED OUT DURING LUNG AND UPPER RESPIRATORY TRACT DISEASES

#12173
20100119566
2010-05-13

Use of a synergistic composition as a therapeutic agent of disinfectant

#12174
20100119563
2010-05-13

Solid fibrinogen preparation

#12175
20100119559
2010-05-13

DOSAGE FORMS OF RISEDRONATE

#12176
20100119557
2010-05-13

Frozen compositions and array devices thereof

#12177
20100119554
2010-05-13

TRANSPLANTS

#12178
20100119542
2010-05-13

FOOD EXTRACTS FOR TREATMENT OF LIPOPROTEIN ABNORMALITIES AND SKIN DISEASES AND SKIN DISORDERS

#12179
20100119531
2010-05-13

Nutraceutical gels

#12180
20100119524
2010-05-13

ADJUVANTED VACCINE

#12181
20100119522
2010-05-13

Combination therapy for the treatment of ocular neovascular disorders

#12182
20100119521
2010-05-13

COMPOSITIONS AND METHODS FOR TREATING CANCER BY MODULATING HER-2 AND EGF RECEPTORS

#12183
20100119516
2010-05-13

Anti-TGF-beta receptor II antibodies

#12184
20100119502
2010-05-13

THERAPY REGIMENS, DOSING REGIMENS AND STABLE MEDICAMENTS FOR THE TREATMENT OF POMPE DISEASE

#12185
20100119498
2010-05-13

Dietary supplement for promoting wellness and weight loss and methods of administering the same

#12186
20100119476
2010-05-13

SELECTION OF PEPTIDES SPECIFIC FOR HUMAN BLOOD OUTGROWTH ENDOTHELIAL CELLS

#12187
20100119471
2010-05-13

bacterin vaccine

#12188
20100119469
2010-05-13

Gynostemma extract surfactant/cleaning agent/emulsifier/foaming agent and method of producing same

#12189
20100115639
2010-05-06

Antibodies inhibiting c-Met dimerization and uses thereof

#12190
20100114547
2010-05-06

Compositions and methods for biological remodeling with frozen particle compositions

#12191
20100114348
2010-05-06

Frozen compositions and methods for piercing a substrate

#12192
20100113615
2010-05-06

Compositions and methods for delivery of frozen particle adhesives

#12193
20100113614
2010-05-06

Compositions and methods for delivery of frozen particle adhesives

#12194
20100113611
2010-05-06

NOVEL USE OF HYDROXYTYROSOL

#12195
20100113607
2010-05-06

Pharmaceutical Compositions

#12196
20100113604
2010-05-06

COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY

#12197
20100113603
2010-05-06

COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY

#12198
20100113602
2010-05-06

USE OF HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM METASTASES

#12199
20100113599
2010-05-06

AMPHIPATHIC CARBOXYLATES FOR THE TREATMENT OF IMMUNE-RELATED DISORDERS

#12200
20100113588
2010-05-06

Composition and methods for the protection of hair from treated pool water

#12201
20100113587
2010-05-06

Abscissic acid and derivatives thereof for the treatment of diseases

#12202
20100113586
2010-05-06

Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms

#12203
20100113583
2010-05-06

COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY

#12204
20100113582
2010-05-06

Methods and compositions for treating HIV infections

#12205
20100113580
2010-05-06

COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY

#12206
20100113578
2010-05-06

Prevention of and countermeasures against mitochondrial disease

#12207
20100113570
2010-05-06

PREVENTION AND TREATMENT OF POST-OPERATIVE COGNITIVE DYSFUNCTION

#12208
20100113569
2010-05-06

ISOLATED DNA FRAGMENT OF THE HUMAN A33 PROMOTER AND ITS USE TO CONTROL THE EXPRESSION OF A HETEROLOGOUS GENE IN TUMOR CELLS

#12209
20100113551
2010-05-06

COMPOSITIONS COMPRISING (S)-2-AMINO-1-(4-CHLOROPHENYL)-1-[4-(1H-PYRAZOL-4-YL)-PHENYL]-ETHANOL AS MODULATOR OF PROTEIN KINASES

#12210
20100113530
2010-05-06

S1P LYASE INHIBITORS FOR THE TREATMENT OF CEREBRAL MALARIA

#12211
20100113521
2010-05-06

Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)

#12212
20100113486
2010-05-06

Use of PDE7 inhibitors for the treatment of movement disorders

#12213
20100113483
2010-05-06

COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS

#12214
20100113478
2010-05-06

INDOLONE MODULATORS OF 5-HT3 RECEPTOR

#12215
20100113474
2010-05-06

Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine

#12216
20100113470
2010-05-06

BCR-ABL variants

#12217
20100113469
2010-05-06

COMBINATION THERAPY FOR THE TREATMENT-OF LOWER URINARY TRACT SYMPTOMS

#12218
20100113452
2010-05-06

Compounds for treating pulmonary hypertension

#12219
20100113427
2010-05-06

COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS

#12220
20100113405
2010-05-06

METHYLINDAZOLE MODULATORS OF 5-HT3 RECEPTORS

#12221
20100113404
2010-05-06

ANTI-ANGIOGENIC ACTIVITY OF 2-METHOXYESTRADIOL ANALOGS IN COMBINATION WITH ANTI-CANCER AGENTS

#12222
20100113403
2010-05-06

Compositions containing compounds having steroid structure and their use for inducing the proliferation and differentiation of stem cells of the organism

#12223
20100113402
2010-05-06

Compositions for treatment of inflammatory diseases

#12224
20100113398
2010-05-06

Treatment and/or Prevention of Non-Viral Epithelial Damage

#12225
20100113396
2010-05-06

Method and composition for potentiating an opiate analgesic

#12226
20100113395
2010-05-06

Low dosage forms of risedronate or its salts

#12227
20100113394
2010-05-06

Low dosage forms of risedronate or its salts

#12228
20100113392
2010-05-06

METHODS OF USING SAHA AND BORTEZOMIB FOR TREATING MULTIPLE MYELOMA

#12229
20100113382
2010-05-06

Combined use of dipeptidyl peptidase 4 inhibitor and sweetener

#12230
20100113379
2010-05-06

cAMP DEPENDENT INDUCTION OF AUTOPHAGY

#12231
20100113378
2010-05-06

Compositions and Methods for Treating and Preventing Cancer Using Analogs of Vitamin D

#12232
20100113377
2010-05-06

Method of treatment using alpha-1-adrenergic agonist compounds

#12233
20100113373
2010-05-06

Antiviral supplement formulations

#12234
20100113361
2010-05-06

Anti-IgE vaccines

#12235
20100113358
2010-05-06

Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta

#12236
20100113352
2010-05-06

RETINOL FORMULATIONS AND METHODS FOR THEIR USE

#12237
20100113347
2010-05-06

EXENATIDE AND DALARGIN-BASED MEDICINAL PREPARATION FOR TREATING PANCREATIC DIABETES

#12238
20100113343
2010-05-06

METHODS INVOLVING LEF-1 REGULATION AND USE OF LEF-1 OR COMPOUNDS ALTERING LEF-1 SIGNALLING FOR TREATING OR PREVENTING DISEASES

#12239
20100113341
2010-05-06

METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE TREATMENT OF CANCER

#12240
20100112188
2010-05-06

NOVEL STABLE BEADLETS OF LIPOPHILIC NUTRIENTS

#12241
20100112162
2010-05-06

25-hydroxy Vitamin Dcompositions

#12242
20100112107
2010-05-06

Plant extract compositions for affecting sleep

#12243
20100112103
2010-05-06

Burn treatment composition and method

#12244
20100112101
2010-05-06

BIO-AVAILABILITY/BIO-EFFICACY ENHANCING ACTIVITY OF STEVIA REBAUDIANA AND EXTRACTS AND FRACTIONS AND COMPOUNDS THEREOF

#12245
20100112093
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#12246
20100112091
2010-05-06

USE OF RAMOPLANIN TO TREAT DISEASES ASSOCIATED WITH THE USE OF ANTIBIOTICS

#12247
20100112088
2010-05-06

MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS

#12248
20100112079
2010-05-06

Thyroid hormone analogs and methods of use

#12249
20100112077
2010-05-06

NANOPARTICLES OF PACLITAXEL AND ALBUMIN IN COMBINATION WITH BEVACIZUMAB AGAINST CANCER

#12250
20100112068
2010-05-06

Compositions and methods for biological remodeling with frozen particle compositions

#12251
20100112067
2010-05-06

Compositions and methods for biological remodeling with frozen particle compositions

#12252
20100112065
2010-05-06

Therapeutic ultrasound gel

#12253
20100112050
2010-05-06

Dosage form for insertion into the mouth

#12254
20100112048
2010-05-06

Dosage Regimen and Medicament For Reducing Risk of Onset or Progression of Dementia by Administration of Specific Vitamins and Nsaid

#12255
20100112047
2010-05-06

Omega 3 fatty acid formulations

#12256
20100112039
2010-05-06

METHODS OF TREATING OVARIAN CANCER

#12257
20100112038
2010-05-06

METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS

#12258
20100112037
2010-05-06

S1P RECEPTOR AGONISTS FOR THE TREATMENT OF CEREBRAL MALARIA

#12259
20100112014
2010-05-06

NOVEL HYDROGEL COMPOSITIONS AND METHODS OF USING

#12260
20100112011
2010-05-06

Photodynamic therapy-generated mesothelioma vaccine

#12261
20100111997
2010-05-06

Multi component vaccine containing clostridial and non-clostridial organisms in a low dose

#12262
20100111973
2010-05-06

METHODS FOR TREATING MICA-RELATED DISORDERS

#12263
20100111965
2010-05-06

COMBINATION THERAPY

#12264
20100111947
2010-05-06

PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY COMPOSITION WHICH SPECIFICALLY BINDS TO GANGLIOSIDE GM2

#12265
20100111945
2010-05-06

NOVEL USES

#12266
20100111942
2010-05-06

Combination therapy for the treatment of ocular neovascular disorders

#12267
20100111941
2010-05-06

METHODS FOR TREATING CANCER

#12268
20100111940
2010-05-06

Compositions containing α-1-antitrypsin and methods for use

#12269
20100111921
2010-05-06

Use of IL-1 antagonists to treat gout

#12270
20100111920
2010-05-06

METHODS AND COMPOSITIONS FOR THE TREATMENT OF VAGINAL DISEASES EMPLOYING PEROXIDE-PRODUCING ENZYMES AND PEROXIDASES

#12271
20100111918
2010-05-06

Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring

#12272
20100111908
2010-05-06

Induction of Renal Cells for Treatment of Kidney Disease

#12273
20100111898
2010-05-06

Conjoint therapy for treating fibrotic diseases

#12274
20100111897
2010-05-06

Methods and compositions useful for diabetic wound healing

#12275
20100111891
2010-05-06

Linear polyol stabilized polyfluoroacrylate compositions

#12276
20100111857
2010-05-06

Compositions and methods for surface abrasion with frozen particles

#12277
20100111855
2010-05-06

Frozen piercing implements and methods for piercing a substrate

#12278
20100111854
2010-05-06

Frozen compositions and methods for piercing a substrate

#12279
20100111850
2010-05-06

Compositions and methods for administering compartmentalized frozen particles

#12280
20100111849
2010-05-06

Compositions and methods for administering compartmentalized frozen particles

#12281
20100111848
2010-05-06

Compositions and methods for administering compartmentalized frozen particles

#12282
20100111847
2010-05-06

Compositions and methods for administering compartmentalized frozen particles

#12283
20100111846
2010-05-06

Compositions and methods for delivery of frozen particle adhesives

#12284
20100111845
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#12285
20100111844
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#12286
20100111842
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#12287
20100111841
2010-05-06

Compositions and methods for surface abrasion with frozen particles

#12288
20100111837
2010-05-06

Compositions and methods for biological remodeling with frozen particle compositions

#12289
20100111836
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#12290
20100111835
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#12291
20100111834
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#12292
20100111833
2010-05-06

Compositions and methods for surface abrasion with frozen particles

#12293
20100106207
2010-04-29

Dynamic nerve stimulation in combination with other eating disorder treatment modalities

#12294
20100105779
2010-04-29

METHODS OF TREATING FIBROMYALGIA SYNDROME, CHRONIC FATIGUE SYNDROME AND PAIN

#12295
20100105778
2010-04-29

METHODS OF TREATING FIBROMYALGIA SYNDROME, CHRONIC FATIGUE SYNDROME AND PAIN

#12296
20100105765
2010-04-29

Combination therapy for treatment of sleep apnea

#12297
20100105743
2010-04-29

Pharmaceutical compositions and methods for stabilizing the same

#12298
20100105701
2010-04-29

Gyrase inhibitors and uses thereof

#12299
20100105688
2010-04-29

PHARMACEUTICAL COMPOSITIONS COMPRISING 3,5-DIAMINO-6-(2,3-DICHLOPHENYL)-1,2,4-TRIAZINE OR R(-)-2,4-DIAMINO-5-(2,3-DICHLOROPHENYL)-6-FLUOROMETHYL PYRIMIDINE AND AN NK1

#12300
20100105685
2010-04-29

S-Nitrosothiol Compounds and Related Derivatives